Cargando…
Low-Dose Immunotherapy: Is It Just an Illusion?
The development and use of immunotherapy in the last decade have led to a drastic improvement in results in the onco-haematological field. This has implied, on the one hand, the need for clinicians to manage a new type of adverse event and, on the other hand, a significant increase in costs. However...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136204/ https://www.ncbi.nlm.nih.gov/pubmed/37189650 http://dx.doi.org/10.3390/biomedicines11041032 |